9 results about "Peripheral thrombosis" patented technology

The invention relates to a collateral-dredging thrombus-removing traditional Chinese medicine composition for preventing and treating stroke, vascular thrombus, arteriosclerosis, coronary heart disease or waist and leg pain. The traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 12-65 parts of cooked rhubarb, 10-72 parts of salvia miltiorrhiza, 12-65 parts of cortex moutan, 6-57 parts of rhizoma zingiberis, 8-50 parts of pseudo-ginseng, 15-45 parts of obscured homalomena rhizome, 10-68 parts of leech, 7-76 parts of earthworm, 15-70 parts of ligusticum wallichii, 6-52 parts of Tibetan capillary artemisia, 7-49 parts of cape jasmine, 3-25 parts of borneol, 6-75 parts of angelica sinensis, 12-65 parts of ginseng, 7-53 parts of pogostemon cablin and 10-77 parts of radix curcumae. The medicine has the effects of promoting blood circulation, removing blood stasis, dredging collaterals and removing thrombus. The traditional Chinese medicine composition can be used for preparing medicines for treating cerebral apoplexy, coronary heart disease, arteriosclerosis and static artery thrombosis diseases, or medicines for soothing channels, activating collaterals and promoting blood circulation to remove blood stasis, which are related to waist and leg pain diseases. The invention provides a prevention and treatment effective solution for people with stroke, vascular thrombosis, arteriosclerosis, coronary heart disease or waist and leg pain.

The present invention relates to comprehensive systems, devices and methods for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In certain embodiments, systems, devices, and methods are provided for treating a tissue region (e.g., a tumor) through application of energy.

The invention discloses a 5 / 8 / 5 chitosan clostridium diterpenoid compound, a biosynthetic gene cluster and application of the biosynthetic gene cluster, and relates to the technical field of biological medicines. A 5 / 8 / 5 chitin type diterpenoid biosynthetic gene cluster Thm in trichoderma harzianum is identified through a genome mining system, chitin diterpenoid compounds with diversified structures are obtained by means of heterologous expression, the obtained compounds are subjected to anti-thrombotic activity comprehensive evaluation, and the result shows that the compounds 6 and 31 can obviously inhibit vascular thrombosis, the compound 6 has a remarkable inhibition effect on collagen-induced platelet aggregation, and the compound 31 has a better inhibition capability on thrombin-induced platelet activation. The compounds 6 and 31 show powerful antithrombotic effects in artery, vein and pulmonary artery thrombosis models, so that powerful technical support is provided for development of antithrombotic drugs.

The present invention relates to comprehensive systems, devices and methods for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In certain embodiments, systems, devices, and methods are provided for delivering energy to difficult to access tissue regions (e.g. peripheral lung tissues), and / or reducing the amount of undesired heat given off during energy delivery.

Provided herein are devices, systems, and methods for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In certain embodiments, devices, systems, and methods are provided for delivering energy to difficult to access tissue regions (e.g. central or peripheral lung tissues), and / or reducing the amount of undesired heat given off during energy delivery.

The present invention provides nanodroplets labeled with targeting ligands that can be used to detect and treat vascular thrombosis (e.g., fibrin clots) and vascular plaques, or related diseases and disorders, as well as methods of making and using the same.

Provided herein are devices, systems, and methods for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In certain embodiments, devices, systems, and methods are provided for delivering energy to difficult to access tissue regions (e.g. central or peripheral lung tissues), and / or reducing the amount of undesired heat given off during energy delivery.